SEC 13F Intelligence

Montchanin Asset Management, LLC / VRTX

Montchanin Asset Management, LLC’s Vertex Pharmaceuticals Inc Position

Does Montchanin Asset Management, LLC own Vertex Pharmaceuticals Inc (VRTX)? Yes — 6.9K shares worth $3M (+3.29% of its 13F portfolio) as of Q1 2026, down from 9.8K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
6.9K
% of Portfolio
+3.29%
Quarters Held
10
currently held

Position History VRTX

Reported value by quarter
Q2 ’22: $1MQ2 ’22Q3 ’22: $1MQ4 ’22: $1MQ4 ’22Q1 ’23: $2MQ2 ’23: $2MQ2 ’23Q1 ’24: $5MQ2 ’24: $5MQ2 ’24Q3 ’24: $5MQ4 ’24: $4MQ4 ’24Q1 ’26: $3Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20266.9K$3M+3.29%
Q4 20249.8K$4M+3.83%
Q3 202411.4K$5M+4.90%
Q2 202410.7K$5M+4.76%
Q1 202411.0K$5M+4.50%
Q2 20236.9K$2M+2.78%
Q1 20236.0K$2M+2.61%
Q4 20224.1K$1M+1.61%
Q3 20223.8K$1M+1.55%
Q2 20223.8K$1M+1.47%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Montchanin Asset Management, LLC’s full portfolio or all institutional holders of VRTX.